Superior Vena Cava Syndrome Secondary to Lung Cancer: A Case Report
Abstract
Superior vena cava syndrome (SVCS) is a clinical condition caused by the obstruction of venous return through the superior vena cava (SVC). This report presents a 71-year-old male diagnosed with central lung cancer and chronic obstructive pulmonary disease (COPD) complicated by SVCS. The report details his clinical presentation, diagnostic
workup, and management, including chemotherapy and symptomatic treatment. SVCS can significantly affect patient outcomes, especially in cases of malignancy, and requires timely intervention.
[1] Straka C, Ying J, Kong FM, Willey CD, Kaminski J, Kim DW. Review of evolving etiologies, implications and treatment strategies for the superior vena cava syndrome. Springerplus. 2016 Feb 29;5:229. https://doi.org/10.1186/s40064-016-1900-7
[2] Lepper PM, Ott SR, Hoppe H, Schumann C, Stammberger U, Bugalho A, et al. Superior vena cava syndrome in thoracic malignancies. Respir Care. 2011 May;56(5):653-66. https://doi. org/10.4187/respcare.00947
[3] Spyratos D, Papadaki E, Lampaki S, Kontakiotis T. Chronic obstructive pulmonary disease in patients with lung cancer: prevalence, impact and management challenges. Lung Cancer (Auckl). 2017 Aug 3;8:101-7. https://doi.org/10.2147/LCTT. S117178
[4] Wan JF, Bezjak A. Superior vena cava syndrome. Hematol Oncol Clin North Am. 2010 Jun;24(3):501-13. https://doi.
org/10.1016/j.hoc.2010.03.003
[5] Lanciego C, Chacón JL, Julián A, Andrade J, López L, Martinez B, et al. Stenting as the first option for endovascular treatment of malignant superior vena cava syndrome. AJR Am J Roentgenol. 2001 Aug;177(3):585-93. https://doi.org/10.2214/ ajr.177.3.1770585
[6] Naliato M, Attinà D, Fabbri M, Agostini A, Russo G, Bazzocchi A, et al. Superior vena cava syndrome: A systematic review. Diagnostics (Basel). 2022 Sep 5;12(9):2133. https://doi. org/10.3390/diagnostics12092133
[7] Yahalom J. Superior vena cava syndrome. In: DeVita VT Jr, Lawrence TS, Rosenberg SA, editors. DeVita, Hellman, and
Rosenberg’s Cancer: Principles and Practice of Oncology. 11th ed. Philadelphia: Wolters Kluwer; 2019. p. 2118-29.
[2] Lepper PM, Ott SR, Hoppe H, Schumann C, Stammberger U, Bugalho A, et al. Superior vena cava syndrome in thoracic malignancies. Respir Care. 2011 May;56(5):653-66. https://doi. org/10.4187/respcare.00947
[3] Spyratos D, Papadaki E, Lampaki S, Kontakiotis T. Chronic obstructive pulmonary disease in patients with lung cancer: prevalence, impact and management challenges. Lung Cancer (Auckl). 2017 Aug 3;8:101-7. https://doi.org/10.2147/LCTT. S117178
[4] Wan JF, Bezjak A. Superior vena cava syndrome. Hematol Oncol Clin North Am. 2010 Jun;24(3):501-13. https://doi.
org/10.1016/j.hoc.2010.03.003
[5] Lanciego C, Chacón JL, Julián A, Andrade J, López L, Martinez B, et al. Stenting as the first option for endovascular treatment of malignant superior vena cava syndrome. AJR Am J Roentgenol. 2001 Aug;177(3):585-93. https://doi.org/10.2214/ ajr.177.3.1770585
[6] Naliato M, Attinà D, Fabbri M, Agostini A, Russo G, Bazzocchi A, et al. Superior vena cava syndrome: A systematic review. Diagnostics (Basel). 2022 Sep 5;12(9):2133. https://doi. org/10.3390/diagnostics12092133
[7] Yahalom J. Superior vena cava syndrome. In: DeVita VT Jr, Lawrence TS, Rosenberg SA, editors. DeVita, Hellman, and
Rosenberg’s Cancer: Principles and Practice of Oncology. 11th ed. Philadelphia: Wolters Kluwer; 2019. p. 2118-29.
Files | ||
Issue | Vol 9 No 3 (2024): May-June | |
Section | Case Report(s) | |
DOI | https://doi.org/10.18502/crcp.v9i3.17238 | |
Keywords | ||
Superior vena cava syndrome Lung cancer Chronic obstructive pulmonary disease Oncology |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Olaiya V, Agyekum V, Omotoso A. Superior Vena Cava Syndrome Secondary to Lung Cancer: A Case Report. CRCP. 2024;9(3):119-124.